LIF (AM424), a promising growth factor for the treatment of ALS

Journal of the Neurological Sciences

Volumn 160, Issue SUPPL. 1, 1998, Pages

  Kurek, John B ^a   Radford, Anthony J ^a   Crump, David E ^a   Bower, John J ^b   Feeney, Sandra J ^b   Austin, Lawrence ^b   Byrne, Edward ^b  

^a Zenyth Therapeutics Limited Australia   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Amyotrophic lateral sclerosis; Growth factor; Leukaemia inhibitory factor; Motor neurone; Regeneration

Indexed keywords

AM 424; LEUKEMIA INHIBITORY FACTOR; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; NERVE FIBER TRANSECTION; NERVE GROWTH; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MICE; MICE, NEUROLOGIC MUTANTS; MUSCLE, SKELETAL; NERVOUS SYSTEM; NEURONS; RECEPTORS, CYTOKINE; REGENERATION; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 0031753245     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00208-1     Document Type: Conference Paper

References (64)

1. Akiyama Y, Kajimura N, Matsuzaki J, Kikuchi Y, Imai N, Tanigawa M, Yamaguchi K. In vivo effect of recombinant human leukemia inhibitory factor in primates. Jpn J Cancer Res 1997;88:578-83.
2. Arakawa Y, Sendtner M, Thoenen H. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurones in culture: comparison with other neurotrophic factors and cytokines. J Neurosci 1990;10:3507-15.
3. Austin L, Burgess AW. Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor. J Neurol Sci 1991;101:193-7.
4. Austin L, Bower J, Kurek J, Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J Neurol Sci 1992;112:185-91.
5. Austin L, Bower J, Kurek JB, Muldoon CM. Controlled release of leukaemia inhibitory factor (LIF) to tissues. Growth Factors 1997;15:61-8.
6. Barnard W, Bower J, Brown M, Murphy M, Austin L. Leukaemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses LIF mRNA. J Neurol Sci 1994;123:108-13.
7. Bauman H, Symes AJ, Comeau MR, Morella KK, Wang Y, Corpus L, Friend D, Ziegler SF, Fink JS, Gearing DP. Multiple regions within the cytoplasmic domains of the leukaemia inhibitory factor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol Cell Biol 1994;14:138-46.
8. Bower J, Vakakis N, Nicola NA, Austin L. The specific binding of leukaemia inhibitory factor to murine myoblasts in culture. J Cell Physiol 1995;164:93-8.
9. Cheema SS, Richards L, Murphy M, Bartlett PF. Leukemia inhibitory factor prevents the death of axotomised sensory neurones in the dorsal root ganglion of the neonatal rat. J Neurosci Res 1994;37:213-8.
10. Cheema SS, Richards LR, Murphy M, Bartlett PF. Leukemia inhibitory factor rescues motorneurones from axotomy-induced cell death. Neuroreport 1994;5:989-92.
11. Curtis R, Scherer SS, Somogyi R, Adryan KM, Ip NY, Zhu Y, Lindsay RM, DiStefano PS. Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased expression in distal nerve. Neurone 1994;12:191-204.
12. Davis S, Yancopoulos GD. The molecular biology of the CNTF receptor. Curr Opin Neurobiol 1993;3:20-4.
13. Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994;145:1271-9.
14. Dittrich F, Ochs G, Grobe-Wilde A, Berweiler U, Yan Q, Miller JA, Toyka KV, Sendtner M. Pharmacokinetics of intrathecally applied BDNF and effects of spinal motor neurones. Exp Neurol 1996;141:225-39.
15. Donato R, Cheema S, Finkelstein D, Bartlett P, Morrison W. The role of leukaemia inhibitory factor (LIF) in rat peripheral nerve regeneration. Ann Acad Med Singapore 1995;4:94-100.
16. Du XX, Williams DA. Interleukin-11: a multifunctional growth factor derived from the hamatopoietic microenvironment. Blood 1994;83:2023-30.
17. Finkelstein D, Bartlett PF, Home MK, Cheema SS. Leukaemia inhibitory factor is a myotrophic and neurotrophic agent that enhances the reinnervation of muscle in the rat. J Neurosci Res 1996;46:122-8.
18. Gearing DP, Thut CJ, Vandebos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckman MP. Leukaemia inhibitory factor receptor is structurally related to the IL-6 signal transducer gp130. EMBO J 1991;10:2839-48.
19. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, Ziegler SF, Cosman D. The IL-6 signal transducer, gp130: an ancostatin M receptor and affinity converter for the LIF receptor. Science 1992;255:1433-7.
20. Gough NM, Gearing DP, King JA, Willson TA, Hilton DJ, Nicola NA, Metcalf D. Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukaemia inhibitory factor. Proc Natl Acad Sci USA 1988;85:2623-7.
21. Gough NM. Molecular genetics of leukaemia inhibitory factor (LIF) and its receptor. Growth Factors 1992;7:175-9.
22. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T. Motor neurone degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772-5.
23. Helgren ME, Squinto SP, Davis HL, Parry DJ, Boulton TG, Heck CS, Zhu Y, Yancopoulos GD, Lindsay RM, DiStefano PS. Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 1994;76:493-504.
24. Hendry IA, Murphy M, Hilton DJ, Nicola NA, Bartlett PF. Binding and retrograde transport of leukaemia inhibitory factor by the sensory nervous system. J Neurosci 1992;12:3427-34.
25. Hibi M, Murukami M, Saito M, Hirano T, Taga T, Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990;63:1149-57.
26. Hibi M, Nakajima K, Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 1996;74:1-12.
27. Hilton DF. LIF: Lots of interesting functions. Trends Biochem Sci 1992;1:72-6.
28. Ikeda K, Iwasaki Y, Shiojima T, Kinoshita M. Neuroprotective effect of cholinergic differentiation leukaemia inhibitory factor on Wobbler murine motor neurone disease. Muscle Nerve 1995;18:1344-7.
29. Ikeda K, Iwasaki Y, Shiojima T, Kinoshita M. Neuroprotective effect of various cytokines on developing spinal motorneurones following axotomy. J Neurol Sci 1996;135:109-13.
30. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a pardigm for cytokines. Science 1992;258:593-7.
31. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-62.
32. Kurek JB, Nouri S, Kannourakis G, Murphy M, Austin L. Leukaemia inhibitory factor and Interleukin-6 are produced in diseased and regenerating skeletal muscle. Muscle Nerve 1996;19:1291-301.
33. Kurek JB, Austin L, Cheema SS, Bartlett PF, Murphy M. Upregulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and denervated muscle. Neuromusc Disord 1996;6:105-14.
34. Kurek JB, Bower J, Romanella M, Kontgen F, Murphy M, Austin L. The role of leukaemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve 1997;20:815-21.
35. Kurek JB, Bennett TM, Bower JJ, Muldoon CM, Austin L. Leukaemia inhibitory factor (LIF) production in a mouse model of spinal trauma. Neurosci Lett 1998;249:1-4.
36. Lai EC, Felice KJ, Festoff BW, Gawel MJ, Gelinas DF, Kratz R, Murphy MF, Natter HM, Norris FH, Rudnicki SA, the North American ALS/IGF-1 Study group. Effect of recombinant human insulin-like growth factor-1 on the progression of ALS: A placebo-controlled study. Neurology 1997:1621-30.
37. Lange DJ, Felice KJ, Festoff BW, Gawel MB, Gelinas DF, Kratz R, Lai EC, Murphy MF, Natter HM, Norris FH, Rudnicki S, the North American ALS/IGF-1 Study group. Recombinant human insulin-like growth factor-1 in ALS: Description of a double-blind, placebo-controlled study. Neurology 1996;47:S93-5.
38. Li M, Sendtner M, Smith A. Essential function of LIF receptor in motor neurones. Nature 1995;378:724-7.
39. Lutticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga T, Kishimoto T, Barbieri G, Pellegrini S, Sendter M, Heinrich PC, Horn F. Association of transcription factor APRF and protein kinase Jakl with the interleukin-6 signal transducer gp130. Science 1994;263:89-92.
40. Martinou J-C, Martinou I, Kato AC. Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic motorneurones in vitro. Neurone 1992;8:737-44.
41. Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, Hoagland RJ, Parry GJ, Ross MA, Stromatt SC, Belsh JM, Buchman AS, Donofrio PD, Eisen AA, Gan RA, Gutman L, Horowitz SH, Jackson WS, Johnston WS, Kelly JJ, Malta E, Mandler RN, Massey JM, McGuire D, Newman DS, the ALS CNTF treatment study group. A placebo controlled trial of recombinant human ciliary neurotrophic factor (rhCNTF) in amyotrophic lateral sclerosis. Ann Neurol 1996;39:246-60.
42. Mitsumoto H, Ikeda K, Holmlund T, Greene T, Cedarbaum JM, Wong V, Lindsay RM. The effects of ciliary neurotrophic factor on motor dysfunction in Wobbler mouse motor neurone disease. Ann Neurol 1994;36:142-8.
43. Murphy M, Reid K, Hilton DJ, Bartlett PF. Generation of sensory neurones is stimulated by leukaemia inhibitory factor. Proc Natl Acad Sci USA 1991;88:3498-501.
44. Murphy M, Reid K, Brown MA, Bartlett PF. Involvement of leukaemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurones. Development 1993;117:1173-82.
45. Penn RD, Kroin JS, York MM, Cedarbaum JM. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery 1997;40:94-9.
46. Pennica D, Ling KL, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rothenthal A, Taga T, Paoini NF, Wood WI. Cardiotrophin-1: Biological activities and binding to the leukaemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 1995;270:10915-22.
47. Pennica D, Arce V, Swanson TA, Vejsada R, Pollock RA, Armanini M, Dudley K, Phillips HS, Rothenthal A, Kato AC, Henderson CE. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long term survivial of spinal motorneurones. Neurone 1996;17:63-74.
48. Richards LJ, Kilpatrick TJ, Bartlett PF, Murphy M. Leukaemia inhibitory factor promotes the neuronal development of spinal cord precursors from the neural tube. J Neurosci Res 1992;33:476-84.
49. Richards LJ, Kilpatrick TJ, Dutton R, Tan S-S, Gearing DP, Bartlett PF, Murphy M. Leukaemia inhibitory factor (LIF) and related factors promote the differentiation of neuronal and astrocytic precursors within the developing murine spinal cord. Eur J Neurosci 1996;8:291-9.
50. Robinson RC, Grey LM, Staunton D, Vankelecom H, Vermallis AB, Moreau J-F, Stuart DI, Heath JK, Jones EY. The crystal structure and biological function of leukaemia inhibitory: implications for receptor binding. Cell 1994;77:1101-16.
51. Rose TM, Bruce G. Oncostatin M is a member of a cytokine family that includes leukaemia inhibitory factor, granulocyte colony-stimulating factor, and interleukin-6. Proc Natl Acad USA 1991;88:8641-5.
52. Sendtner M, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurones after axotomy. Nature 1990;345:440-1.
53. Sendtner M, Schmalbruch H, Stockli KA, Carrol P, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurones in mouse mutant progressivve motor neuropathy. Nature 1992;358:502-4.
54. Stahl N, Boulton TG, Farrugella T, Ip NY, Davis S, Witthuhn A, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, Ihle JN, Yancopoulos GD. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components. Science 1994;263:92-4.
55. Stahl N, Farrugella T, Boulton TG, Zhong Z, Darnell JE, Yancopoulos G. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995;267:1349-53.
56. Taga T, Hibi M, Hirata Y, Yamasaki K, Yusukawa K, Matsuda T, Hirano T, Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989;58:573-81.
57. Taga T, Kishimoto T. Cytokine receptors and signal transduction. FASEB J 1992;6:3387-96.
58. Tham S, Dowsing B, Finkelstein D, Donato R, Cheema SS, Bartlett PF, Morrison W. Leukaemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J Neurosci Res 1997;47:208-15.
59. Vakakis N, Bower J, Austin L. In vitro myoblast to myotube transformations in the presence of leukaemia inhibitory factor. Neurochem Int 1995;27:329-35.
60. Weidau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesen DE. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-8.
61. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988;366:684-7.
62. Yakch TL, Rathbun ML, Dragini JC, Malkmus S, Bourdeau AM, Richter P, Powell H, Myers RR, LeBel CP. Kinetic and safety studies on intrathecally infused recombinant-methionyl human brain-derived neurotrophic factor in dogs. Fundam Appl Toxicol 1997;38:89-100.
63. Yamakuni H, Minami M, Satoh M. Localisation of mRNA for leukaemia inhibitory factor receptor in the adult brain. J Neuroimmunol 1996;70:45-53.
64. Yamamori T, Fukada K, Aebersold R, Korsching S, Famm M-J, Patterson PH. The cholinergic neuronal differentiation factor from heart cells is identical to leukaemia inhibitory factor. Science 1989;246:1412-6.